KH906

KH906滴眼液

Report date: 2024/08/22 20:00:11

Base Information

Drug NameKH906
Drug Alias NameKH-906
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsKeratitisCorneal Neovascularization
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesChengdu Kanghong Biotechnologies Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesChengdu Kanghong Biotechnologies Co Ltd
Active IndicationsN/A
Inactive IndicationsKeratitisCorneal Neovascularization

Other Information

ATC CodeN/A
Related LinksN/A